Home > Insider Trading > Filing (0001209191-17-049511)

Filing Details

Accession Number:: 0001209191-17-049511
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-08-17 19:01:42
Reporting Period:: 2017-08-15

Filing Date:: 2017-08-17
Accepted Time:: 2017-08-17 19:01:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1685071	Dova Pharmaceuticals Inc.	DOVA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494695	B Paul Manning	200 Garrett Street, Suite S Charlottesville VA 22902		Yes	No	Yes	No
1665309	Pbm Capital Investments, Llc	200 Garrett Street, Suite S Charlottesville VA 22902		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-08-15	13,000	$21.16	113,000	No	4	P	Direct
Common Stock	Acquisiton	2017-08-15	7,870	$22.39	120,870	No	4	P	Direct
Common Stock	Acquisiton	2017-08-16	3,521	$24.87	124,391	No	4	P	Direct
Common Stock	Acquisiton	2017-08-16	1,379	$25.62	125,770	No	4	P	Direct
Common Stock	Acquisiton	2017-08-16	100	$26.81	125,870	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,783,226	Indirect	By LLC
Common Stock	12,214,953	Indirect	By LLC

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.96 - $21.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
These shares are held by the Reporting Person together with his spouse as Joint Tenants with Right of Survivorship.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.00 - $22.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.41 - $25.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.41 - $26.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
These shares are held by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of BKB and, as such, has unilateral voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of the shares held by BKB except to the extent of his pecuniary interest therein, and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
These shares are held by PBM Capital Investments, LLC ("PBM"). The Reporting Person has the sole voting and investment power with respect to the shares held by PBM. The Reporting Person disclaims beneficial ownership of the shares held by PBM except to the extent of his pecuniary interest therein, and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.